RE:Pet Deal benchmark - Signed a license agreement for a first-in-class product for feline diabetes care. The daily oral medication is under FDA regulatory review and is expected to be approved in the next 12 months.
looks like there will be no animal health deal for Sirona. Elanco has another product which is already under FDA review. Sirona can't compete with that, because they can't go further then prelinical state.